Streetbeat News

Regulatory

SGMT

Sagimet Biosciences presented promising data from its FASCINATE-2 Phase 2B trial of Denifanstat at the European Association for the Study of the Liver Congress. The drug achieved statistically significant results in improving liver fibrosis and was generally well tolerated.

Portfolio Pulse from Benzinga Newsdesk

June 06, 2024 | 9:08 am

AMZN

GOOGL

TSLA

Amazon's self-driving unit Zoox will begin testing in Austin, Texas, and Miami, marking its fourth and fifth public testing locations. Competitors include Alphabet's Waymo and Tesla, with GM's Cruise resuming manual driving in Phoenix and Dallas. The NHTSA is investigating Zoox vehicles for sudden braking issues.

Portfolio Pulse from Anan Ashraf

June 06, 2024 | 9:01 am

TOUR

Tuniu Corporation has regained compliance with Nasdaq's minimum bid price requirement.

Portfolio Pulse from Benzinga Newsdesk

June 06, 2024 | 6:36 am

META

Meta Platforms Inc (NASDAQ:META) is facing 11 privacy complaints from the EU regarding its proposed use of personal data to train AI models. The complaints, filed by advocacy group NOYB, argue that Meta's changes would breach EU privacy regulations by using personal data without user consent. This comes amid ongoing scrutiny of Meta's privacy practices and legal challenges in both the EU and the U.S.

Portfolio Pulse from Benzinga Neuro

June 06, 2024 | 5:53 am

BTCUSD

ETHUSD

VanEck

VanEck has updated its Ethereum price prediction for 2030 to $22,000, citing the potential of Ether ETFs, Ethereum’s scaling progress, and on-chain data analysis. The firm is seeking approval to list a spot Ether ETF and anticipates significant inflows once approved.

Portfolio Pulse from Aniket Verma

June 06, 2024 | 4:34 am

LULU

META

NVDA

TSLA

TSM

On Wednesday, the U.S. stock market saw gains with the Dow Jones, S&P 500, and Nasdaq all rising. Key stocks that gained attention included Nvidia, Meta, Taiwan Semiconductor, Lululemon, and Tesla. Nvidia reached a $3 trillion market cap, Meta faced scrutiny over acquisitions, Taiwan Semiconductor benefited from compliance with U.S. sanctions, Lululemon beat revenue estimates, and Tesla's FSD updates frustrated some subscribers.

Portfolio Pulse from Benzinga Neuro

June 06, 2024 | 2:33 am

LULU

OPTHF

Optimi Health Corp. (OTC:OPTHF) has received a license to export psilocybin and MDMA to Australia, marking a significant milestone in the medical psychedelic drugs market. The company aims to become a key player in the manufacture of pharmaceutical-grade psychedelics. Despite regulatory challenges in the U.S., Optimi is positioning itself for global market leadership.

Portfolio Pulse from Rolando García

June 06, 2024 | 1:12 am

SNGX

Trading for SNGX was halted at 7:50:00 p.m. ET due to pending news.

Portfolio Pulse from Benzinga Newsdesk

June 05, 2024 | 11:50 pm

SSNT

Trading for SSNT was halted at 7:50:00 p.m. ET due to pending news. Investors should stay tuned for further updates.

Portfolio Pulse from Benzinga Newsdesk

June 05, 2024 | 11:50 pm

FSLR

RUN

SEDG

SPWR

Several solar stocks, including First Solar, Sunrun, SolarEdge Technologies, and SunPower, rallied on Wednesday due to reports of lawmakers pushing for an investigation into Chinese solar firms for allegedly evading U.S. tariffs. Despite the positive movement, Goldman Sachs maintained a Sell rating on SunPower and lowered its price target.

Portfolio Pulse from Vaishali Prayag

June 05, 2024 | 9:28 pm